Triazolines XV. Anticonvulsant Profile of ADD 17014, a Potentially Unique 1,2,3‐Triazoline Antiepileptic Drug, in Mice and Rats

Medicine and Dentistry

• Anticonvulsant 100%
• Phenobarbital 100%
• Pentylenetetrazol 83%
• Bicuculline 83%
• Maximal Electroshock Seizure 83%
• Sodium Valproate 83%
• In Vitro 50%
• Glutamic Acid 50%
• Picrotoxin 50%
• Oral 50%
• Oral Drug Administration 33%
• Indican 33%
• Ethosuximide 33%
• Prodrug 33%
• Phenytoin 33%
• Epileptic Seizure 16%
• Glutamate Receptor 16%
• Intraperitoneal Drug Administration 16%
• Receptor Binding 16%
• Electric Shock 16%
• Excitatory Amino Acid Receptor Antagonist 16%
• Anticonvulsant Activity 16%
• Aminoalcohol 16%
• Metabolite 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Phenobarbital 100%
• Anticonvulsive Agent 100%
• Sodium Valproate 83%
• Pentetrazole 83%
• Bicuculline 83%
• Maximal Electroshock Seizure 83%
• Picrotoxin 50%
• Glutamic Acid 50%
• Median Toxic Dose 50%
• Prodrug 33%
• Phenytoin 33%
• Indican 33%
• Ethosuximide 33%
• Oral Administration 33%
• Anticonvulsant Activity 16%
• Amino Acid Receptor Blocking Agent 16%
• Receptor 16%
• Electric Shock 16%
• Strychnine 16%
• Aminoalcohol 16%
• Glutamate Receptor 16%

Arts and Humanities

• Oral 100%
• Crisis 20%
• Exceptions 20%
• Spectre 20%
• Antagonist 20%
• Alto 20%
• Originales 20%
• Family Novel 20%